Intermittent BRAF-inhibitor therapy is a feasible option: report of a patient with metastatic melanoma. (Q54409415)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Intermittent BRAF-inhibitor therapy is a feasible option: report of a patient with metastatic melanoma. |
scientific article |
Statements
Intermittent BRAF-inhibitor therapy is a feasible option: report of a patient with metastatic melanoma. (English)
A Koop
I Satzger
M Alter
A Kapp
A Hauschild
R Gutzmer
1 January 2014
170
1
220-222
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference